Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT03023904
Brief Title:
Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads
Official Title:
Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads
Study:
NCT03023904
Protocol Section:
NCT03023904